Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Ind-Swift Laboratories Limited (NSE: INDSWFTLAB)

 
INDSWFTLAB Technical Analysis
4
As on 24th Apr 2024 INDSWFTLAB SHARE Price closed @ 123.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 95.47 & Buy for SHORT-TERM with Stoploss of 110.40 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

INDSWFTLABSHARE Price

Open 124.50 Change Price %
High 125.35 1 Day -0.65 -0.53
Low 122.20 1 Week 2.25 1.86
Close 123.10 1 Month 22.25 22.06
Volume 432712 1 Year 57.10 86.52
52 Week High 123.40 | 52 Week Low 53.40
 
NSE INDIA Most Active Stocks
IDEA 13.10 -9.03%
SAIL 164.65 8.14%
YESBANK 25.45 -0.78%
TATASTEEL 165.55 2.73%
IRFC 149.00 0.85%
SOUTHBANK 29.10 1.04%
MRPL 248.70 10.75%
SUZLON 41.80 -0.12%
BEL 236.50 0.92%
RAMASTEEL 14.00 2.56%
 
NSE INDIA Top Gainers Stocks
ROML 63.05 19.98%
COMPUSOFT 35.20 19.93%
SHRADHA 78.55 19.83%
STEELCITY 102.95 19.78%
WEIZMANIND 142.25 19.59%
TEMBO 240.90 18.61%
CHENNPETRO 1075.00 15.82%
YUKEN 1180.65 13.81%
ORIENTCEM 230.50 12.85%
AEGISCHEM 604.50 12.41%
 
NSE INDIA Top Losers Stocks
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
BBL 3320.90 -51.12%
IDEA 13.10 -9.03%
IDEA 13.10 -9.03%
IDEA 13.10 -9.03%
HUHTAMAKI 318.00 -8.19%
SHK 206.60 -7.64%
SHK 206.60 -7.64%
 
 
INDSWFTLAB
Daily Charts		 INDSWFTLAB
Intraday Charts		 Whats New @
Bazaartrend		 INDSWFTLAB
Free Analysis
 
INDSWFTLAB Important Levels Intraday
RESISTANCE129.17
RESISTANCE127.22
RESISTANCE126.02
RESISTANCE124.82
SUPPORT121.38
SUPPORT120.18
SUPPORT118.98
SUPPORT117.03
 
INDSWFTLAB Target April 2024
Share
4th UP Target164.81
3rd UP Target147.57
2nd UP Target136.91
1st UP Target126.26
1st DOWN Target95.84
2nd DOWN Target85.19
3rd DOWN Target74.53
4th DOWN Target57.29
 
INDSWFTLAB Weekly Target
4th UP Target153.38
3rd UP Target142.23
2nd UP Target135.33
1st UP Target128.44
1st DOWN Target108.76
2nd DOWN Target101.87
3rd DOWN Target94.97
4th DOWN Target83.82
 
INDSWFTLAB Target2024
4th UP Target239.89
3rd UP Target196.16
2nd UP Target169.14
1st UP Target142.11
1st DOWN Target64.99
2nd DOWN Target37.96
3rd DOWN Target10.94
4th DOWN Target-32.79
 
 
INDSWFTLAB Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
 Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 50.49 Sideways
MFI (14) MFI is 46.81 Sideways
CCI (20) CCI is 13.92 Sideways
WILLIAM %R (14) William %R is -28.07 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 15.06
10 Day Avg Volume Traded 60.16 % More then 10 Day Average Volume
 
INDSWFTLAB Other Details
Segment EQ
Market Capital 3701794304.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
INDSWFTLAB Address
INDSWFTLAB
 
INDSWFTLAB Latest News
 
Your Comments and Response on Ind-Swift Laboratories Limited
 
INDSWFTLAB Business Profile
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India. Address: Shivalik Enclave, Manimajra, India, 160101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service